Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Nausea × nabiximols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Marijuana Abuse 3 Pain 2 Neoplasms 2 Glioblastoma 2 Signs and Symptoms 1 Recurrence 1 Parasomnias 1 Pancreatic Neoplasms 1 Nausea 1 Marijuana Use 1 Cancer Pain 1 Cachexia 1 Brain Neoplasms 1 Anxiety Disorders 1 Anorexia 1 Advanced Malignant Solid Tumor 1 1- Cancer Patients During Chemotherapy Treatment 1

Interventions

Dexamethasone 25 Aprepitant 23 Palonosetron 18 Ondansetron 18 Calcium Dobesilate 13 Olanzapine 12 Granisetron 11 Therapeutics 7 fosaprepitant 6 Doxorubicin 6 Cyclophosphamide 6 dexamethasone acetate 5 netupitant 4 Vincristine 4 dolasetron 3 Tropisetron 3 Prochlorperazine 3 Metoclopramide 3 Lorazepam 3 Dronabinol 3 Acupressure 3 peppermint oil 2 netupitant, palosentron drug combination 2 ginger extract 2 dexamethasone 21-phosphate 2 Surveys and Questionnaires 2 Sugars 2 Rituximab 2 Radiotherapy 2 Psychiatric Rehabilitation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡